Federated Hermes Inc. Acquires 82,502 Shares of Azenta, Inc. (NASDAQ:AZTA)

Federated Hermes Inc. boosted its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 29.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 365,506 shares of the company's stock after acquiring an additional 82,502 shares during the quarter. Federated Hermes Inc. owned 0.66% of Azenta worth $23,809,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in AZTA. TFC Financial Management Inc. bought a new stake in Azenta during the 3rd quarter worth approximately $25,000. Headlands Technologies LLC bought a new stake in shares of Azenta in the 3rd quarter valued at $33,000. Neo Ivy Capital Management bought a new stake in shares of Azenta in the 3rd quarter valued at $73,000. Covestor Ltd boosted its stake in shares of Azenta by 17.5% in the 3rd quarter. Covestor Ltd now owns 1,714 shares of the company's stock valued at $86,000 after purchasing an additional 255 shares during the last quarter. Finally, Allworth Financial LP boosted its stake in shares of Azenta by 273.1% in the 4th quarter. Allworth Financial LP now owns 1,634 shares of the company's stock valued at $106,000 after purchasing an additional 1,196 shares during the last quarter. 99.08% of the stock is owned by institutional investors.

Azenta Stock Up 0.5 %

NASDAQ AZTA traded up $0.26 on Monday, hitting $50.91. 409,763 shares of the company were exchanged, compared to its average volume of 428,093. Azenta, Inc. has a 12 month low of $36.01 and a 12 month high of $69.16. The stock has a fifty day moving average of $60.68 and a 200-day moving average of $59.05.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings data on Wednesday, February 7th. The company reported $0.02 earnings per share for the quarter. Azenta had a negative net margin of 2.92% and a positive return on equity of 0.49%. The firm had revenue of $154.32 million for the quarter, compared to the consensus estimate of $151.86 million. As a group, sell-side analysts forecast that Azenta, Inc. will post 0.27 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently commented on AZTA. Jefferies Financial Group began coverage on shares of Azenta in a research note on Thursday, April 4th. They issued a "hold" rating and a $64.00 price objective on the stock. Stephens reaffirmed an "equal weight" rating and issued a $70.00 price objective on shares of Azenta in a research note on Thursday, February 8th. Needham & Company LLC reaffirmed a "buy" rating and issued a $75.00 price objective on shares of Azenta in a research note on Monday, April 8th. Evercore ISI cut their target price on shares of Azenta from $64.00 to $60.00 and set an "in-line" rating on the stock in a research note on Thursday, April 4th. Finally, B. Riley increased their target price on shares of Azenta from $61.00 to $79.00 and gave the stock a "buy" rating in a research note on Thursday, February 1st. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Azenta has a consensus rating of "Hold" and a consensus price target of $69.60.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.